financetom
Business
financetom
/
Business
/
Janus Henderson Group Insider Sold Shares Worth $262,852, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Janus Henderson Group Insider Sold Shares Worth $262,852, According to a Recent SEC Filing
Nov 9, 2024 11:42 AM

04:52 PM EST, 11/06/2024 (MT Newswires) -- Michelle Rosenberg, Chief Administrative Officer and General Counsel, on November 04, 2024, sold 6,314 shares in Janus Henderson Group ( JHG ) for $262,852. Following the Form 4 filing with the SEC, Rosenberg has control over a total of 82,923 shares of the company, with 82,799 shares held directly and 124 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1274173/000143774924033646/xslF345X05/rdgdoc.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Dominion Energy Q3 Non-GAAP Earnings, Revenue Rise; Narrows 2025 Non-GAAP Earnings Guidance
Dominion Energy Q3 Non-GAAP Earnings, Revenue Rise; Narrows 2025 Non-GAAP Earnings Guidance
Oct 31, 2025
07:51 AM EDT, 10/31/2025 (MT Newswires) -- Dominion Energy ( D ) reported Q3 non-GAAP earnings on Friday of $1.06 per share, up from $0.98 a year earlier. Analysts polled by FactSet expected $0.95. Operating revenue for the quarter ended Sept. 30 was $4.53 billion, compared with $3.94 billion a year earlier. Analysts polled by FactSet expected $4.25 billion. The...
Cboe Global Markets Q3 Adjusted Earnings, Revenue Rise
Cboe Global Markets Q3 Adjusted Earnings, Revenue Rise
Oct 31, 2025
07:47 AM EDT, 10/31/2025 (MT Newswires) -- Cboe Global Markets ( CBOE ) reported Q3 adjusted earnings Friday of $2.67 per diluted share, up from $2.22 a year earlier. Analysts polled by FactSet expected $2.54. Net revenue for the quarter ended Sept. 30 was $605.5 million, compared with $532 million a year earlier. Analysts surveyed by FactSet expected $590.5 million....
AGCO's Q3 Adjusted Earnings Increase, Net Sales Decline; 2025 Adjusted EPS Outlook Updated
AGCO's Q3 Adjusted Earnings Increase, Net Sales Decline; 2025 Adjusted EPS Outlook Updated
Oct 31, 2025
07:47 AM EDT, 10/31/2025 (MT Newswires) -- AGCO ( AGCO ) reported Q3 adjusted earnings Friday of $1.35 per share, up from $0.69 a year earlier. Analysts polled by FactSet expected $1.22. Net sales for the quarter ended Sept. 30 were $2.48 billion, compared with $2.60 billion a year earlier. Analysts polled by FactSet expected $2.46 billion. The company said...
AbbVie lifts annual profit forecast on resilient demand for newer immunology drugs
AbbVie lifts annual profit forecast on resilient demand for newer immunology drugs
Oct 31, 2025
Oct 31 (Reuters) - AbbVie ( ABBV ) raised its 2025 profit forecast on Friday, after strong sales of newer immunology drugs Skyrizi and Rinvoq helped boost third-quarter results above Wall Street estimates. The North Chicago-based drugmaker has been leaning on Skyrizi and Rinvoq to offset declining sales of its once best-selling arthritis treatment Humira that began facing biosimilar competition...
Copyright 2023-2026 - www.financetom.com All Rights Reserved